Review Article
Melatonin against Myocardial Ischemia-Reperfusion Injury: A Meta-analysis and Mechanism Insight from Animal Studies
Table 3
The molecular and cellular mechanisms underlying the cardioprotection of melatonin treatment in myocardial I/R injury.
| Studies | Year | Proposed mechanisms |
| Chen et al. | 2018 | Inhibit autophagy via AMPK/mTOR signaling pathway | Zhou et al. | 2017 | Attenuate FUNDC1-required mitophagy, inflammation, improve microvascular function via regulating the expression of platelet PPARγ | Zhai et al. | 2017 | Antioxidative stress, antiapoptosis through activation of SIRT3 signaling pathway | Zhou et al. | 2017 | Regulate mitochondrial fission, mitophagy, mPTP opening, and HK2-VDAC1 interaction | He et al. | 2016 | Restore autophagy function, suppress oxidative stress and apoptosis through nuclear receptor RORα | Yu et al. | 2015 | Notch1/Hes1 signaling and Pten/Akt signaling underlie the antioxidative stress and antiapoptosis effect | Yu et al. | 2014 | Reduce apoptosis and oxidative damage via SIRT1 signaling | Chen et al. | 2009 | Attenuate apoptosis independent of Gpx1 | Genade et al. | 2008 | Antiadrenergic actions mediated by NO and PKC signaling, PKB/Akt activation, and p38MAPK signaling involved in the cardioprotection | Lochner et al. | 2006 | NA | Sahna et al. | 2004 | Attenuate oxidative stress (reduce MDA and restore GSH level) | Sahna et al. | 2002 | NA | Lee et al. | 2002 | Antioxidant activity, inhibit neutrophil infiltration | Lagneux et al. | 2000 | NA | Nduhirabandi et al. | 2010 | Prevent metabolic abnormality via modulating insulin release and PKB/Akt and ERK 1/2 signaling |
|
|